These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35777669)

  • 1. Inhibition of a broad range of SARS-CoV-2 variants by antiviral phytochemicals in hACE2 mice.
    Kim EH; Lee BW; Ryu B; Cho HM; Kim SM; Jang SG; Casel MAB; Rollon R; Yoo JS; Poo H; Oh WK; Choi YK
    Antiviral Res; 2022 Aug; 204():105371. PubMed ID: 35777669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach.
    Maurya DK; Sharma D
    J Biomol Struct Dyn; 2022 Jun; 40(9):3949-3964. PubMed ID: 33251972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
    Idrees M; Khan S; Memon NH; Zhang Z
    Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
    Azeem M; Mustafa G; Mahrosh HS
    Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral effects of phytochemicals against severe acute respiratory syndrome coronavirus 2 and their mechanisms of action: A review.
    Jantan I; Arshad L; Septama AW; Haque MA; Mohamed-Hussein ZA; Govender NT
    Phytother Res; 2023 Mar; 37(3):1036-1056. PubMed ID: 36343627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model.
    Péricat D; Leon-Icaza SA; Sanchez Rico M; Mühle C; Zoicas I; Schumacher F; Planès R; Mazars R; Gros G; Carpinteiro A; Becker KA; Izopet J; Strub-Wourgaft N; Sjö P; Neyrolles O; Kleuser B; Limosin F; Gulbins E; Kornhuber J; Meunier E; Hoertel N; Cougoule C
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of anti-SARS-CoV-2 and anti-inflammatory potential of baicalein and its metabolite baicalin: Insights into molecular mechanisms.
    Dinda B; Dinda M; Dinda S; De UC
    Eur J Med Chem; 2023 Oct; 258():115629. PubMed ID: 37437351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.
    Anand AV; Balamuralikrishnan B; Kaviya M; Bharathi K; Parithathvi A; Arun M; Senthilkumar N; Velayuthaprabhu S; Saradhadevi M; Al-Dhabi NA; Arasu MV; Yatoo MI; Tiwari R; Dhama K
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33809963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curative Potential of High-Value Phytochemicals on COVID-19 Infection.
    Sruthi D; Dhanalakshmi M; Rao HCY; Parthasarathy R; Deepanraj SP; Jayabaskaran C
    Biochemistry (Mosc); 2023 Jan; 88(1):64-72. PubMed ID: 37068882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp.
    Murali M; Gowtham HG; Ansari MA; Alomary MN; Alghamdi S; Almehmadi M; Singh SB; Shilpa N; Aiyaz M; Kalegowda N; Ledesma AE; Amruthesh KN
    Curr Pharm Des; 2022; 28(12):969-980. PubMed ID: 35796443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.
    Liu X; Mostafavi H; Ng WH; Freitas JR; King NJC; Zaid A; Taylor A; Mahalingam S
    mBio; 2022 Jun; 13(3):e0068322. PubMed ID: 35420469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational investigation for identification of potential phytochemicals and antiviral drugs as potential inhibitors for RNA-dependent RNA polymerase of COVID-19.
    Singh J; Malik D; Raina A
    J Biomol Struct Dyn; 2022 May; 40(8):3492-3507. PubMed ID: 33200678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
    Abdurrahman L; Fang X; Zhang Y
    Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.
    Forchette L; Sebastian W; Liu T
    Curr Med Sci; 2021 Dec; 41(6):1037-1051. PubMed ID: 34241776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Activity of N
    Siniavin AE; Novikov MS; Gushchin VA; Terechov AA; Ivanov IA; Paramonova MP; Gureeva ES; Russu LI; Kuznetsova NA; Shidlovskaya EV; Luyksaar SI; Vasina DV; Zolotov SA; Zigangirova NA; Logunov DY; Gintsburg AL
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.
    Agrawal S; Pathak E; Mishra R; Mishra V; Parveen A; Mishra SK; Byadgi PS; Dubey SK; Chaudhary AK; Singh V; Chaurasia RN; Atri N
    Comput Biol Med; 2022 Oct; 149():106049. PubMed ID: 36103744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Umadevi P; Manivannan S; Fayad AM; Shelvy S
    J Biomol Struct Dyn; 2022 Jul; 40(11):5053-5059. PubMed ID: 33372574
    [No Abstract]   [Full Text] [Related]  

  • 20. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.